Marshall Wace, LLP Trans Medics Group, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 546,787 shares of TMDX stock, worth $71.7 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
546,787
Previous 152,447
258.67%
Holding current value
$71.7 Million
Previous $10.3 Million
614.45%
% of portfolio
0.09%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding TMDX
# of Institutions
413Shares Held
29.7MCall Options Held
1.15MPut Options Held
763K-
Vanguard Group Inc Valley Forge, PA3.6MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$347 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$169 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$138 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$125 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.17B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...